These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10704117)

  • 1. Impurity profiling in bulk pharmaceutical batches using 19F NMR spectroscopy and distinction between monomeric and dimeric impurities by NMR-based diffusion measurements.
    Mistry N; Ismail IM; Farrant RD; Liu M; Nicholson JK; Lindon JC
    J Pharm Biomed Anal; 1999 Mar; 19(3-4):511-7. PubMed ID: 10704117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of impurities in bulk drug batches of fluticasone propionate using directly coupled HPLC-NMR spectroscopy and HPLC-MS.
    Mistry N; Ismail IM; Smith MS; Nicholson JK; Lindon JC
    J Pharm Biomed Anal; 1997 Dec; 16(4):697-705. PubMed ID: 9502165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impurity Profile of Bronchodilators used in Asthma: A Critical Review.
    Prajapati KJ; Kothari CS
    Curr Drug Discov Technol; 2018; 15(4):272-304. PubMed ID: 28875855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levothyroxine sodium revisited: A wholistic structural elucidation approach of new impurities via HPLC-HRMS/MS, on-line H/D exchange, NMR spectroscopy and chemical synthesis.
    Ruggenthaler M; Grass J; Schuh W; Huber CG; Reischl RJ
    J Pharm Biomed Anal; 2017 Feb; 135():140-152. PubMed ID: 28024262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification, Characterization and High-Performance Liquid Chromatography Quantification for Process-Related Impurities in Abiraterone Acetate Bulk Drug.
    Hu C; Zhang H; Zhang M; Mi Z; Wang J; Lu W; Su J
    J Chromatogr Sci; 2018 Oct; 56(9):802-811. PubMed ID: 30007288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fenofibrate raw materials: HPLC methods for assay and purity and an NMR method for purity.
    Lacroix PM; Dawson BA; Sears RW; Black DB; Cyr TD; Ethier JC
    J Pharm Biomed Anal; 1998 Nov; 18(3):383-402. PubMed ID: 10096833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Impurity Profiling Methods Using Modern Analytical Techniques.
    Ramachandra B
    Crit Rev Anal Chem; 2017 Jan; 47(1):24-36. PubMed ID: 27070830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NMR and mass spectrometric characterization of vinblastine, vincristine and some new related impurities--part II.
    Háda V; Dubrovay Z; Lakó-Futó A; Galambos J; Gulyás Z; Aranyi A; Szántay C
    J Pharm Biomed Anal; 2013 Oct; 84():309-22. PubMed ID: 23177164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of LC-NMR to the identification of bulk drug impurities in NK1 antagonist GW597599 (vestipitant).
    Provera S; Guercio G; Turco L; Curcuruto O; Alvaro G; Rossi T; Marchioro C
    Magn Reson Chem; 2010 Jul; 48(7):523-30. PubMed ID: 20535779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of d-Cycloserine Impurities in Pharmaceutical Dosage Forms: Comparison of the International Pharmacopoeia HPLC-UV Method and the DOSY NMR Method.
    Makuc D; Švab Ž; Naumoska K; Plavec J; Časar Z
    Molecules; 2020 Apr; 25(7):. PubMed ID: 32272592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation, structure characterization and quantification of related impurities in asperosaponin VI.
    Ji D; Liu YF; Wang QH; Zhang CF; Yang ZL
    Chin J Nat Med; 2013 Jul; 11(4):419-26. PubMed ID: 23845554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceutical impurities and degradation products: uses and applications of NMR techniques.
    Maggio RM; Calvo NL; Vignaduzzo SE; Kaufman TS
    J Pharm Biomed Anal; 2014 Dec; 101():102-22. PubMed ID: 24853620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generic ciprofloxacin tablets contain the stated amount of drug and different impurity profiles: A 19F, 1H and DOSY NMR analysis.
    Trefi S; Gilard V; Malet-Martino M; Martino R
    J Pharm Biomed Anal; 2007 Jul; 44(3):743-54. PubMed ID: 17446031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impurity profile study of loratadine.
    Reddy KV; Babu JM; Kumar YR; Reddy SV; Kumar MK; Eswaraiah S; Reddy KR; Reddy MS; Bhaskar BV; Dubey PK; Vyas K
    J Pharm Biomed Anal; 2003 Apr; 32(1):29-39. PubMed ID: 12852446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification, characterization and HPLC quantification of process-related impurities in Trelagliptin succinate bulk drug: Six identified as new compounds.
    Zhang H; Sun L; Zou L; Hui W; Liu L; Zou Q; Ouyang P
    J Pharm Biomed Anal; 2016 Sep; 128():18-27. PubMed ID: 27209451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversed-phase liquid chromatography with electrospray mass detection and 1H and 13C NMR characterization of new process-related impurities, including forced degradants of efavirenz: related substances correlated to the synthetic pathway.
    Gadapayale K; Kakde R; Sarma VU
    J Sep Sci; 2015 Jan; 38(2):218-30. PubMed ID: 25385054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Estimation of impurity profiles of drugs and related materials. 20. Methodological problems in the identification and determination of organic impurities].
    Görög S
    Acta Pharm Hung; 2000; 70(3-6):131-7. PubMed ID: 11379019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid and comprehensive impurity profiling of synthetic thyroxine by ultrahigh-performance liquid chromatography-high-resolution mass spectrometry.
    Neu V; Bielow C; Gostomski I; Wintringer R; Braun R; Reinert K; Schneider P; Stuppner H; Huber CG
    Anal Chem; 2013 Mar; 85(6):3309-17. PubMed ID: 23394260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of potential impurities of rabeprazole sodium.
    Reddy GM; Bhaskar BV; Reddy PP; Sudhakar P; Babu JM; Vyas K; Reddy PR; Mukkanti K
    J Pharm Biomed Anal; 2007 Mar; 43(4):1262-9. PubMed ID: 17134865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.